Moving Towards a Competitive European Bioeconomy: Emerging Biorefinery Technologies & Pathways to Deployment
For Europe to move towards a competitive bioeconomy, is it is essential that biorefinery technologies developed in the lab and at pilot scale are upscaled and deployed at an industrial scale. Industry and policy makers must work together to create commercial pathways to this greener future – but how?
This interactive event brings together researchers, industry leaders and policy makers to discuss how the European bioeconomy can take green technology from idea to deployment and who needs to do what to make this happen.
Short agenda:
13:00 Introductions and keynote from the EU
13:30 Technical sessions – project achievements Feedstock, processes and new products Interactive session with audience Q&A
15:00 Coffee break
15:30 First panel session From idea to deployment – an industry view
16:15 Second panel session Rollout of biorefinery technology – policy perspective
The event is organised by two EU-funded SPIRE projects, Bio4Products and Rehap, both successful in identifying biomass availability and developing innovative new conversion processes and bio-based products. The projects have received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreements number 723070 and 723670 respectively.
Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.
Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.
The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.
Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.
Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.
Algal Omage-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of algal omega-3 used.